# Early Postprocedural Susceptibility-Weighted Imaging and Vessel-Wall Imaging For Prediction of Complications After Flow-Diversion Treatment

> **NCT05716360** · — · UNKNOWN · sponsor: **Uludag University** · enrollment: 60 (estimated)

## Conditions studied

- Early Susceptibility-Weighted Imaging and Vessel-Wall Imaging Findings After Flow-Diversion Treatment of Intracranial Aneurysms

## Interventions

- **DIAGNOSTIC_TEST:** Pre-procedural, early and late post-procedural susceptibility weighted imaging and vessel wall imaging with a 3T Magnetic Resonance Imaging Device
- **PROCEDURE:** Aneurysm Treatment with Flow-Diversion Therapy
- **PROCEDURE:** Aneurysm Treatment with Metalic Bare Stent

## Key facts

- **NCT ID:** NCT05716360
- **Lead sponsor:** Uludag University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-28
- **Primary completion:** 2024-12-30
- **Final completion:** 2025-04-28
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05716360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05716360, "Early Postprocedural Susceptibility-Weighted Imaging and Vessel-Wall Imaging For Prediction of Complications After Flow-Diversion Treatment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05716360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
